Clinical Trial Update: Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document summarizes the completion of a Phase 2 trial evaluating thalidomide in patients with extensive-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED